Patheon Inc

Patheon — Q2 2012 Earnings Presentation

16 slides from Patheon's earnings presentation, Jun 13, 2012

  1. Slide 1: Fiscal 2012 Second Quarter Earnings

    Patheon Fiscal 2012 Second Quarter Earnings June 13, 2012 Exhibit 99.2

  2. Slide 2: Forward-Looking Statements

    Forward-Looking Statements This presentation contains forward-looking statements or information which reflect our expectations regarding possible events, conditions, our future growth, results of operations, performance, and business prospects and opportunities. All statements, other than statements

  3. Slide 3: Agenda

    Agenda • Highlights • Financial results • Transformation update • Conclusion

  4. Slide 4: Second Quarter Highlights

    Second Quarter Highlights 18.9% revenue growth* Significant increase in gross profit* * Excluding the $17.4M benefit from the contract cancellation reco rded in the second quarter of fiscal 2011 Raising revenue guidance - in excess of $725M Transformation on track

  5. Slide 5: Revenue Overview

    Revenue Overview Q2 2011 Q3 2011 Q4 2011 Q1 2012 Q2 2012 18.9% yr-yr revenue growth excluding the benefit from contract cancellation Revenue (U.S. $ in millions) Adjusted Revenue (U.S. $ in millions) Q2 2011 Q3 2011 Q4 2011 Q1 2012 Q2 2012

  6. Slide 6: Gross Profit Overview

    Gross Profit Overview Q2 2011 Q3 2011 Q4 2011 Q1 2012 Q2 2012 Gross Profit (U.S. $ in millions) Q2 2011 Q3 2011 Q4 2011 Q1 2012 Q2 2012 Gross profit growth from $13M to $34M excluding the benefit from contract cancellation Adjusted Gross Profit (U.S. $ in millions)

  7. Slide 7: Adjusted EBITDA Overview

    Adjusted EBITDA Overview -15 -5 Q2 2011 Q3 2011 Q4 2011 Q1 2012 Q2 2012 Adjusted EBITDA (U.S. $ in millions) Adjusted EBITDA Excluding Certain Items (U.S. $ in millions) -15 -5 Q2 2011 Q3 2011 Q4 2011 Q1 2012 Q2 2012

  8. Slide 8: Summary Financial Results

    Summary Financial Results Three months ended April 30, Statement of Operations (in millions of U.S. dollars) $ $ Revenues 181.5 170.0 Gross profit 34.0 30.4 Selling, general and administrative expenses 34.7 24.8 Operating (loss) income (64.6) 4.7 Loss before discontinued operations (79.6) (10.3) Adj

  9. Slide 9: Strategy

    Strengthen core operations Sell business differently Enter logical adjacencies Drive industry consolidation Strategy

  10. Slide 10: Strengthen core operations

    Strengthen core operations Mindsets & Behaviors Infrastructure Leveraging global network Swindon announcement Clinical packaging Puerto Rico consolidation on track Improving resource coordination Lab design and work flow Expanding operational capacity Italy pre-filled syringe line G&A and procuremen

  11. Slide 11: Sell business differently

    Sell business differently Value-drive solutions for our customers: Expanded CMC and Scientific Consulting offerings to position the brand differently: Patheon Certified Consultants

  12. Slide 12: Launched P-Gels in May: Enter logical adjacencies

    Launched P-Gels in May Enter logical adjacencies Leverages expertise of both companies Patheon – sales and marketing reach and largest development pipeline ProCaps – softgel related technology, formulation and manufacturing expertise, and infrastructure

  13. Slide 13: Summary

    Summary • Underlying business is strong with growing revenues and improving margins • Transformation activities are on track • Balance sheet and liquidity are good • Raising top-line guidance

  14. Slide 14: Thank You

    Thank You

  15. Slide 15: Appendix: Adjusted Revenue and Gross Profit

    Appendix Adjusted Revenue (unaudited) Q211 Q311 Q411 Q112 Q212 (in millions of U.S. dollars) $ $ $ $ $ Revenues 170.0 172.7 181.6 153.9 181.5 Contract cancellation (17.4) - - - - Adjusted Revenue 152.6 172.7 181.6 153.9 181.5 Adjusted Gross Profit (unaudited) Q211 Q311 Q411 Q112 Q212 (in millions of

  16. Slide 16: Appendix: Adjusted EBITDA Reconciliation

    Appendix Adjusted EBITDA and Adjusted EBITDA Excluding Certain Items (unaudited) Q2 2011 Q3 2011 Q4 2011 Q1 2012 Q2 2012 (in millions of U.S. dollars) $ $ $ $ $ Loss before discontinued operations (10.3) 0.6 (9.8) (19.3) (79.6) Depreciation and amortization 13.5 12.6 12.2 10.6 10.8 Repositioning exp

Patheon — Q2 2012 Earnings Presentation on 6ix